Wednesday, October 4, 2023
Wednesday, October 4, 2023

Contact: 561.316.3330

JN White Introduces the SnaggleClaw™

J.N. White Associates, Inc. (announced today that it is launching the SnaggleClaw™: a new multipurpose, touchless tool that limits exposure to pathogens.

The JN White ®  SnaggleClaw™is to be used in situations where an individual risks exposure to COVID-19.

This tool provides a safer alternative to touching in everyday activities, such as operating touchscreens, keypads and door handles. In addition, the tool contains an antimicrobial coating that offers an additional layer of defense against pathogens.

JN White® is an ISO 9001:2015 and ITAR-certified custom manufacturer specializing in the design and production of membrane switches, graphic overlays and custom labels. The company works with a wide range of global companies in many industries including military/DoD, medical devices and appliances. In response to the coronavirus pandemic, JN White® moved into the development and production of Personal Protective Equipment (PPE).

When asked why the firm continues to expand into new PPE products, JN White® President, Jason Aymerich, explains, “JN White® continues to innovate where the market has a need.  Providing solutions in the PPE space furthers the firm’s commitment to helping our country stay strong.”

SplatterGuard and SnaggleClaw are trademarks of J.N. White Associates, Inc. JN White and Precision Answers are registered trademarks of J.N. White Associates, Inc. 

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Centinel Spine’s prodisc ® Continues to Change Lives After Over 30 Years and 250,000 Total Disc Replacement Implantations

The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany (October 4-6, 2023). The prodisc technology portfolio now includes four cervical and two lumbar devices—5 approved by the FDA—and has been validated with a reported reoperation rate of less than 1%.

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. 

RaySearch Deepens Collaboration with P-Cure

The expanded collaboration will enable users of the P-Cure proton therapy system to use RayStation and RayCare in a seamlessly integrated environment. The P-Cure system is a gantry-less seated proton system, designed to fit within linac vaults, that has recently been cleared by the FDA. It is used clinically by the Hadassah Medical Center in Jerusalem – the only proton facility in the Middle East – to treat CNS, head and neck, thoracic and pancreatic malignancies.

Edinburgh-based Med-tech Firm in MBO to Expand Into New Markets and Technologies

The acquisition will enable Novarum to build on its strong lateral flow test customer base and extend into adjacent markets. 

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.

By using this website you agree to accept Medical Device News Magazine Privacy Policy